ArticleCurrent medicinal chemistry2025

A Risk Model Developed based on Homologous Recombination Deficiency Genes for Evaluating the Drug Sensitivity and Prognostic Prediction of Lung Adenocarcinoma.

Lingling Hong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.